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Oxytocin is a nine-amino acid peptide hormone and/or neuropeptide that has 
proposed mechanisms related to diminishing the effects of physical, psychological, and 
psychosocial stress. Exercise is often used in clinical trials to quantify stress because it is 
easily reproducible between subjects using relative VO2 intensities. However, trials 
examining plasma oxytocin in response to physical stress within exercise have shown 
mixed results possibly related to the varied measurement techniques. The purpose of this 
study is to measure plasma oxytocin changes in response to steady state exercise and 
graded maximal exercise and to determine if a relationship exists. Procedures were 
utilized to release oxytocin from the protein binding within blood and measure the 
oxytocin concentration through a high-performance liquid chromatography coupled to a 
mass spectrometer. Difficulties in the chromatography detection sensitivity forced the 
present study to also use an ELISA to determine plasma oxytocin concentrations. Plasma 
oxytocin concentrations were consistently too low to detect even after sizable spiking for 
both measurement techniques. Mean resting concentration derived from the ELISA was 
371.75 ± 215.10 pg/ml. There was no significant difference in concentration following 
either exercise stimulus. These results suggest that the extraction technique utilized with 
the ELISA kit failed to separate protein binding from oxytocin prior to analysis. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 With the ever-increasing prevalence of documented anxiety disorders, it is 
becoming more important to better understand these disorders. Researching proposed 
biomarkers associated with anxiety disorders may help us better diagnose and treat 
anxiety. In 2013, the total healthcare cost for mental disorders was $201 billion, which 
was higher than many other diseases and conditions (Roehrig et al. 2016). Of all the 
psychiatric conditions, anxiety disorders are the most common and have a lifetime 
prevalence close to 30% in the United States (Kessler et al. 2008, Naja et al. 2017). 
Anxiety disorders are typically characterized by more than the normal amount of worry 
and fear. Based on the NIMH website, “People with generalized anxiety disorder display 
excessive anxiety or worry for months and face several anxiety-related symptoms.”  
These symptoms include: restlessness or feeling wound-up or on edge, being easily 
fatigued, difficulty concentrating or having their minds go blank, irritability, muscle 
tension, difficulty controlling their worry, and sleep problems (difficulty falling or 
staying asleep or restless, unsatisfying sleep). One of the risk factors associated with 
social anxiety disorders is elevated cortisol levels in the afternoon and higher resting 
plasma oxytocin concentrations. 
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Often, therapy is suggested to help with anxiety disorders. This may include talk 
therapy, cognitive behavioral therapy, support groups, stress-management techniques, 
and medication. These interventions often enable the person to cope with the disorder but 
typically does not cure the person of the disorder. There is some evidence that aerobic 
exercise has a calming effect in some individuals, but the quality of the results from these 
studies are not strong enough to support its use as treatment. The 1996 Surgeon General’s 
Report on Physical Activity and Health concluded that feelings of anxiety are reduced 
with regular physical activity. One of the suggested reasons for aerobic exercise to treat 
anxiety is related to the effects of various hormonal signals including catecholamines, 
cortisol, and oxytocin (Naja et al. 2017).  
 Exercise is often seen as an anxiety and stress-reducing activity; however, it could 
also be a cause of anxiety and stress if the exercise is too difficult (intense) or unfamiliar. 
Cortisol is an acute stress related hormone that is induced by activation of the HPA axis 
and is elevated within the blood in response to intense exercise (Brown et al. 2016). A 
stress stimulus will result in a cascade of effects within the HPA axis and stimulate the 
synthesis of cortisol in the adrenal cortex as well as release of catecholamines from the 
adrenal medulla. The type, intensity and duration of the stress will affect cortisol 
concentration. Exercise will stimulate cortisol increases in the circulation depending on 
the intensity and duration of the exercise. Anxiety-related stress could be in relation to 
the rise in blood cortisol released in response to exercise (Whirledge et al. 2010). Cortisol 
is released as a result of intense exercise to increase glucose formation (gluconeogenesis) 
and, thus, provide more carbohydrate fuel for the intense exercise (Whirledge et al. 2010, 
3 
 
Castro-Vale et al. 2016). High blood concentration of this glucocorticoid is correlated 
with stress, fear, pain, psychological stress, and many different anxiety disorders (Brown 
et al. 2016, Castro-Vale et al. 2016). In contrast, oxytocin has been theorized to have a 
suppressive effect on cortisol release and, therefore, may have an anxiolytic effect (Naja 
et al. 2017).  
 Oxytocin is a neuropeptide that could change the way anxiety disorders’ 
treatments evolve. This neuropeptide has been reported in multiple studies to increase 
trust and social bonding and to reduce anxiety in response to stressful situations (Naja et 
al. 2017). Oxytocin in response to exercise has had mixed results and appears to be 
related to several factors, such as type and duration of exercise as well as exercise 
intensity (Hew-Butler et al. 2008). Salivary oxytocin was shown to increase significantly 
following 10 minutes of running in both men and women with higher levels reported for 
women (Jong et al. 2016). The exercise increase was similar to or greater than the 
increases with a standardized Trier Social Stress Test (TSST) in these same individuals. 
The cortisol response was elevated in these individuals in saliva but was at a later time 
(Jong et al. 2016). Blood cortisol levels do not significantly elevate until roughly 30 
minutes after a stress stimulus. It must be activated by a cascade effect from the 
hypothalamus and pituitary gland before being synthesized in the adrenal cortex and 
subsequently released. In contrast, acute changes in oxytocin were reported not to be 
elevated after a high-intensity steady state run for 60 min but did increase after an 
ultramarathon (Hew-Butler et al. 2008). The response to a maximal graded exercise test 
reported a non-significant increase from 1.3 to 2.6 pg/ml in this study. The non-
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significant result may possibly be related to a small sample size (n=7), as well as the 
large variation in oxytocin levels in this study. Another factor which may contribute to 
the lack of consistency in the literature with oxytocin changes with exercise is the 
procedures utilized to measure this molecule. In this thesis it has been attempted to 
follow the procedures by Brandtzaeg et al. to purify the plasma samples (2016). 
Purpose 
 The purpose of this study is to determine the changes of plasma oxytocin in a 
healthy population in response to a graded exercise test and a moderate intensity 30-
minute exercise to understand if plasma oxytocin is related to exercise intensity and or 
duration. 
Objective and Hypotheses 
 Although oxytocin has been measured in response to social stress, few studies 
have recorded its response to exercise. Understanding oxytocin concentration’s response 
to exercise may give us a better understanding of the role of exercise in stress reduction. 
It is hypothesized that oxytocin concentration will significantly increase in response to 
graded maximal exercise. In contrast, it is hypothesized that 30 minutes of sustained 
aerobic moderate intensity exercise (70-75% VO2max) will not provide sufficient intensity 
to induce a significant increase in plasma oxytocin concentration. It is unclear if there 
will be a relationship between the change in cortisol and the change in oxytocin due to 
secretion of cortisol occurring later in time post exercise. Salivary oxytocin peaks in 
concentration about 10-15 minutes after psychological and physical stress stimulus, 
whereas salivary cortisol does not peak until 35 minutes after stimulus (Jong et al. 2015).  
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 Finally, there is a conflict in the normal resting oxytocin concentration. 
Depending on the extraction and analysis methods, researches have reported baseline 
levels as low as 1 pg/ml and as high as 1000 pg/ml. Recently, liquid chromatography and 
mass spectrometry was used to directly measure plasma oxytocin and reported baseline 
plasma levels around 600-800 pg/ml. Brandtzaeg et al. 2016 suggests that better 
extraction of oxytocin is needed. Oxytocin binds strongly to proteins in the blood and 
requires precise extraction for accurate measurement. Commercial radio immunoassays 
and enzyme immunoassays kits that include extraction sometimes fail to depict true 
plasma oxytocin levels. Some showed levels two magnitudes higher than normal 
(McCullough et al. 2013). Although some RIAs possess lower limits of quantification 
(LLOQ) as low as 0.49 pg/ml, RIAs being an indirect measure opens itself up to 
disruption in the form of pH variation and extra binding to macromolecules in biological 
samples (Zhang et al. 2011). High pressure liquid chromatography paired with mass 
spectrometry may alleviate some of the inaccuracies of the above-mentioned methods. 
Quantitative measurements of endogenous oxytocin are challenging because of the low 
concentration that may be found in human plasma. While few methods of HPLC-MS 
analysis of oxytocin are available, some have shown LLOQs as low as 1.00 pg/ml (Zhang 
2011). This approach may be the best for determination of basal oxytocin levels with 
high sensitivity. Liquid chromatography results were compared with enzyme linked 
immunosorbent assay (ELISA) results to determine validity of the two procedures. 
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 Therefore, this thesis hopes to report the baseline levels of a healthy young cohort 
at rest and to determine if oxytocin in this cohort will be elevated immediately after these 
two types of acute exercise. 
Assumptions and Limitations 
 Subjects were apparently healthy and had not exercised for at least 24 hours prior 
to testing. The subjects came into the lab after an overnight fast and were adequately 
hydrated. Subjects were non-tobacco users for at least 6 months prior to the study, had 
normal resting blood pressure and were not abnormally anxious.  
 All subjects had normal resting blood pressures and were not obese based on 
seven site skin fold. Only apparently young subjects (18-35 years of age) were recruited, 
so the results may not reflect what may occur in older individuals. This is a small cohort 
of subjects and, therefore, may not reflect what can occur in all subjects. All subjects 
reported in a post-absorptive state and thus these values may not be similar in a fed state. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
General Oxytocin Information 
 Oxytocin (OXT) is a neuropeptide as well as a peptide hormone that plays a 
critical role in social recognition, anxiety, and childbirth (Naja et al. 2017). Although 
OXT has been well researched in childbirth, there has been limited research studies 
observing the effect of physical stress on OXT response (Brown el al. 2016, Hew-Butler 
et al. 2010). Oxytocin is synthesized in the magnocellular neurosecretory cell of the 
paraventricular nucleus and the supraoptic nuclei in the hypothalamus. Oxytocin is 
secreted from the posterior pituitary into the hypothalamic pituitary adrenal axis (HPA 
axis). As the name implies, this axis is the collection of the following three endocrine 
glands: the hypothalamus, the anterior and posterior lobes of the pituitary gland, and the 
adrenal cortex. Oxytocin has also been shown to be secreted within the brain and from 
the ovaries and testes. The common feedback loop that occurs in this axis is the 
regulation of the glucocorticoid cortisol (Castro-Vale et al. 2016). Oxytocin is 
hypothesized to have a role in this regulatory process, but the exact function is unclear. It 
is currently believed that OXT may have an inhibitory effect on corticotropin-releasing 
hormone (CRH) to limit the secretion of cortisol and reduce the stress response (Naja et 
al. 2017). Thus, OXT has an important anxiolytic regulatory effect on the HPA axis. 
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OXT may be regulated in part by catecholamines. The adrenergic system has dual control 
over oxytocin with α-receptor activation increasing secretion while β-receptor activation 
demonstrating an inhibitory effect on secretion (Song et al. 1988).  
 The oxytocin effect is determined by its binding and activation of its receptor the 
oxytocin receptor (OXTR). OXTR is coupled to a G protein receptor located in the 
membrane to work within several brain regions. Although OXTR mapping has not been 
completely done in humans, there has been a good deal of research in rodents and 
primates. In these animals, OXTR was located in the spinal cord, brainstem, 
hypothalamus, amygdala, accumbens nucleus, hippocampus, and anterior cingulate 
cortex (Naja et al. 2017). These brain regions with OXTR present are involved in social 
reward, emotion and memory. Recently, studies observing the human brain during 
intranasal OXT administration observed reduced activation of the amygdala (Naja et al. 
2017, Mottolese et al. 2014). This introduces the idea that the amygdala is largely 
involved in the role of oxytocin and stress regulation with a possible interaction with 
serotonin (Mottolese et al. 2014). 
 Oxytocinase is an enzyme in the aminopeptidase family that is responsible for the 
metabolism of oxytocin (Tsujimoto et al. 2004). Oxytocinase deactivates oxytocin by 
cleaving the peptide bond between the N-terminal cysteine and the adjacent tyrosine 
residues. Because of its similar structure and location, vasopressin is also easily degraded 
by oxytocinase. Enzyme expression of oxytocinase could have effects on the sensitivity 
and effect of oxytocin and vasopressin in the human body. Oxytocin has a half-life of 
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about 7-15 minutes in rats depending on the concentration with longer times with very 
high doses (Morin et al. 2008). 
Factors Affecting Oxytocin Synthesis and Release 
 Biosynthesis of oxytocin begins with the synthesis of an inactive precursor 
protein, which gets progressively hydrolyzed and cleaved into smaller parts. Within the 
paraventricular nucleus or supraoptic nucleus, which lie within the hypothalamus, 
oxytocin is hydrolyzed one final time to its active nonapeptide form by the enzyme 
Peptidyl-glycine alpha-amidating monooxygenase (PaM). Although it is synthesized in 
both regions, oxytocin is more prevalent in the paraventricular nuclei. PaM’s function is 
dependent on a binding cofactor of sodium ascorbate or vitamin C. This hydrolyzation 
process also yields neurophysin I, the carrier protein for oxytocin (Landgraf et al. 1981). 
The correlation of plasma concentration of both neurophysin I and oxytocin supports this 
carrier synthesis theory (Brownstein et al. 1980). Both levels will increase in response to 
dehydration and lactation (Dax et al. 1978).  
Oxytocin Anxiolytic Effects 
 It is currently unknown what the specific mechanisms are that regulate the 
secretion of OXT outside its role in childbirth. There are, however, distinct rises in OXT 
blood plasma concentration following sexual stimulation, childbirth, anxiety, and 
hyperosmolarity (Naja et al. 2017, Brown et al. 2016, Hew-Butler et al. 2010). Functional 
magnetic resonance imaging (fMRI) has been used in humans to determine behavioral 
and cognitive responses to OXT. Observing the brain after OXT administration has 
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shown increased activity in the cortical and subcortical regions of the cerebral cortex, 
temporal lobes, amygdala, and prefrontal cortex (Naja et al. 2017).  
 Both oxytocin and serotonin are significant neuromodulators that influence social 
interaction, stress, and anxiety. Recent animal studies have reported a direct anatomical 
link between the two brain regions carrying these transmitters. Serotonergic fibers 
originating in the dorsal and medial raphe nuclei of the brainstem connect to the 
paraventricular nuclei and the supraoptic nuclei (Mottolese et al. 2014). Further 
investigation has shown oxytocin receptors in the raphe nuclei, the place of serotonin 
synthesis. Oxytocin infusions in animals have noted increased serotonin concentration 
and infusion of serotonin increases oxytocin (Mottolese et al. 2014). Therefore, both 
neuromodulators work in tandem to react to varying social stimuli, such as fear and social 
bonding.  
Anxiety Disorders and Oxytocin 
 Brain oxytocin activity can be used to categorize emotional and social behaviors 
(Neumann et al. 2012). High anxiety levels can be related to an imbalance of OXT 
systems. This can be a result of reduced OXT gene expression, reduced central nervous 
system OXT release or availability, low OXTR expression, or an imbalance of AVP and 
OXT (Neumann et al. 2012, Naja et al. 2017). Contrary to the evidence of OXT’s 
anxiolytic effects, many studies have shown increased peripheral OXT is related to 
increased anxiety and distress (Brown et al. 2016). High levels of plasma OXT were 
correlated with reduced depressive symptoms in women with psychological stress 
(Zelkowitz et al, 2014). They suggested that the plasma OXT was there to attenuate or 
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mitigate the psychological and physiological stress and this is supported by Heinrich et 
al. 2003. In male subjects with post-traumatic stress disorder, a lower concentration of 
salivary OXT was observed compared to trauma control subjects (Naja et al. 2017). This 
is in line with many other animal studies where plasma, salivary fluid, and cerebral spinal 
fluid OXT concentrations were lower in general anxiety disorders (GAD) subjects 
compared to normal subjects (Jong et al. 2015). 
 Oxytocin and arginine vasopressin (AVP) work together to regulate anxiety as 
well as regulating fluid volume. It is believed both neurotransmitters are released in 
response to anxiety and have opposite effects (Neumann et al. 2012). Acting in the 
amygdala, oxytocin modulates neuronal functions to reduce emotional responsiveness 
and stress. Oxytocin has mostly been studied in response to psychological stress as 
opposed to physical stress. Arginine vasopressin is released in tandem with OXT during 
both psychological and physical stress inducing situations. AVP typically has an 
anxiogenic response, and high expression of AVP receptors in brain regions is linked to 
increased social anxiety (Neumann et al. 2012). With exercise that results in changes in 
plasma volume loss, AVP will be elevated to try to conserve water loss through the 
kidneys.  
Relationship of Cortisol and Stress 
 In response to a stressful or traumatic event, the paraventricular nucleus in the 
hypothalamus releases corticotrophin-releasing hormone (CRH) and vasopressin, both of 
stimulate adrenocorticotropic hormone (ACTH) to be secreted from the anterior pituitary 
(Raymond et al. 2017). This cascade effect in the HPA axis results in ACTH stimulation 
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of adrenal cortex synthesis and secretion of cortisol. This cortisol contributes to the 
mobilization of the body’s energy sources in preparation for action. In turn, the cortisol 
rise will inhibit CRH and ACTH to create a negative feedback loop. 
 Cortisol release and its subsequent effects play a critical role in stress regulation, 
and cortisol is commonly used as a stress biomarker (Raymond et al. 2017). Cortisol 
prepares the body for stress and influences many different systems of the body. Because 
of its lipid-solubility, it passes the blood brain barrier easily to affect a multitude of brain 
regions. These include but are not limited to the following: the amygdala, the 
hippocampus, the prefrontal cortex, and the anterior pituitary.  
Oxytocin Effect on Cortisol 
 Pharmaceutical stress treatments using intranasal and intravenous OXT 
administration have been shown to reduce the effect of stress (Naja et al. 2017). There is 
evidence that exogenous oxytocin can inhibit CRH in the HPA axis while arginine 
vasopressin enhances CRH release (Raymond et al. 2017). Decreased plasma cortisol was 
noted following intravenous and intranasal oxytocin administration in response to stress 
(Naja et al. 2017, Cardoso et al. 2013). Although this information may lead to a more 
fine-grained understanding of the mechanism for OXT release, it has not been 
unanimously reported in human studies. It also appears oxytocin has a dose-dependent 
response for cortisol (Cardoso et al. 2013). Intranasal administration of oxytocin during 
vigorous exercise only had a reduced cortisol release with a 24IU dose. Meanwhile, 
subjects that received a 48IU dose had similar cortisol concentrations to control subjects 
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(Cardoso et al. 2013). It is unclear what the most effective dose of oxytocin may be for 
stress reduction. 
 fMRI scans of the human brain have shown that both OXT and cortisol have 
receptors in a number of the same brain regions, including the amygdala, hippocampus, 
prefrontal cortex, and the anterior pituitary (Raymond et al. 2017, Naja et al. 2017, 
Mottolese et al. 2014). In the amygdala, the stress response initiated by cortisol elicits a 
strong emotional response, such as fear or anxiety. The oxytocin and serotonin interaction 
within the amygdala lessens this emotional response (Mottolese et al. 2014). An excess of 
cortisol can impair the hippocampus’ ability to encode and recall information. The result 
of this is an impaired ability to recall information during stressful situations. At the same 
time, the emotional response enhances memory consolidation to improve the memory of 
the stressful event after the fact (Payne et al. 2007). Oxytocin’s role in these brain regions 
is largely unknown. However, oxytocin administration has resulted in attenuated 
emotional response and improved memory during stress (Neumann et al. 2008).  
Hydration’s Role in Peripheral Oxytocin 
 Arginine vasopressin (AVP) and aldosterone are the principle hormones 
responsible for fluid balance. These hormones are secreted in response to increased blood 
osmolarity and decreased blood volume. Vasopressin stimulates vasopressin receptor 2 
(V2) receptors in the kidney tubule to promote water retention (Hew-Butler et al. 2010). 
Aldosterone stimulates mineralocorticoid receptors in the distal kidney tubules to 
increase sodium reabsorption. Vasopressin secretion is very sensitive to osmolarity with 
significant AVP release following only a 1-2% change in blood osmolarity (Hew-Butler 
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et al. 2010). The AVP response to exercise has been well documented, but changes in 
plasma osmolarity during exercise are only partially the result of a direct effect of AVP 
(Hew-Butler et al. 2010). During exercise, aldosterone is activated at a lower exercise 
intensity than AVP. During times when there is increased intensity, both AVP and 
aldosterone work together to retain water as plasma volume is lost.  
 Oxytocin and AVP are synthesized in the same regions and have very similar 
structure. Both hormones only differ by two amino acid groups. With such similarities, 
the two hormones tend to have an overlap in receptor activation. Oxytocin may be 
responsible for some of the differences in osmolarity during exercise. OXT can stimulate 
the V2 receptors on the kidney similarly to AVP but needs a 100-fold higher 
concentration to have the same effect as AVP (Hew-Butler et al. 2010). Therefore, OXT 
is likely not a major factor for fluid balance as the osmolarity concentration within the 
circulation does not increase to that extent, even with exercise that demonstrates 
osmolarity increases. However, fluid balance shifts may stimulate oxytocin release in 
similar manners as vasopressin release. This needs to be addressed in research focused on 
oxytocin in situations where subjects may experience fluid loss. 
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Oxytocin and Acute Exercise 
 The effect of acute exercise on oxytocin is under-researched. The few studies 
available currently do not show much change in plasma OXT concentrations in response 
to exercise (Chicharro et al. 2001). Jong et al. 2015 observed salivary oxytocin in 
response to psychosocial stress, sexual stimulation, and physical exercise. All three 
stimuli showed similar responses with peaks at the end of stimulation and a gradual 
recovery over time. The physical exercise was running at a self-selected pace for 10 
minutes. Salivary oxytocin rose from about 2 pg/ml resting to close to 5 pg/ml directly 
post-run. Testing was done at home, and participants collected their own saliva. 
 Hew-Butler et al. 2008 showed no change in plasma oxytocin following a graded 
treadmill max test and a 60-minute steady state at 60% peak running speed. However, a 
significant increase in plasma oxytocin was observed after an ultramarathon, 1.5 pg/ml 
prior ultramarathon and 3.5 pg/ml post. It was hypothesized that this increase was not due 
to the exercise stimulus but was, instead, from the extreme fluid loss. This study had only 
seven participants, and each of them were highly-trained endurance runners. The 
endocrine response to this physical exercise may be attenuated in the endurance runners 
compared to the normal population. 
 Chicharro et al. 2001 explored the differences that training status had on plasma 
oxytocin’s response to exercise. They used a cycling ramp protocol and measured plasma 
oxytocin at rest, below the lactate threshold, above the threshold, and at VO2max. They 
reported no plasma OXT change in both groups to the various intensities. They did 
observe lower OXT concentrations in the trained group compared to the untrained, about 
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10 pg/ml and 18 pg/ml respectively. These values are slightly higher than the previously 
established basal levels of 1-10 pg/ml (McCullough et al. 2013, Zhang et al. 2011) and 
suggest that preparation of the plasma samples may be a factor as to why exercise had no 
influence on the OXT concentration. 
 Altemus et al. 2001 examined the differences in female sex hormone, oxytocin, 
and vasopressin responses to exercise and compared these responses in the varying 
phases of the menstrual cycle. An exercise test with 5-minute stages at 50%, 70%, and 
90% VO2 max was utilized. No significant change in OXT was noted immediately post-
exercise nor during a 40-minute recovery. 
  
 
 
 
1
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Table 1. Summary of Acute Exercise Training Effect on Oxytocin 
Study Subjects Exercise Modality 
Pre-Ex [OXT] 
(pg/ml) 
Post-Ex [OXT] 
(pg/ml) 
Assay Tissue 
Chicharro et al. 
2001 
Trained vs 
Untrained cyclists 
Ramp cycling till 
exhaustion 
Trained ~10 
Untrained ~18 
Trained ~10 
Untrained ~18 
RIA Plasma 
Hew-Butler et al. 
2008 
Trained Endurance 
Runners 
Graded treadmill VO2 
max test 
1.3 (0.2) 2.6 (0.7) RIA Plasma 
Hew-Butler et al. 
2008 
Trained Endurance 
Runners 
60 minute steady state 
at 60% VO2 max 
1.1 (0.3) 1.5 (0.1) RIA Plasma 
Hew-Butler et al. 
2008 
Trained Endurance 
Runners 
56km ultramarathon 1.5 (0.2) 3.5 (0.5)* RIA Plasma 
Jong et al. 2016 Healthy Adults 
10 minutes of self-
selected moderate 
running 
~2.0 ~5.0* RIA Saliva 
* Denotes significantly different from pre-exercise oxytocin p<0.05. 
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Oxytocin and Chronic Exercise Training 
 Very little is known about how training status influences oxytocin dynamics in 
humans. The lack of evidence makes it difficult to draw any conclusions on the 
implications of endurance training. In the only study that was found that compared 
trained cyclist (n=12) versus untrained athletes (n=10), trained subjects had significantly 
lower plasma OXT levels at rest (10 pg/dl), during exercise below lactate threshold, 
during exercise above lactate threshold, and at maximal exercise compared to untrained 
(17-18 pg/dl) (Chicharro et al. 2001). Both groups showed no change in OXT with 
exercise. OXT was measured using a radioimmunoassay kit by Phoenix Pharmaceutical 
after passing samples through a Sep-Pak C18 cartridge. The authors attributed the 
reduced OXT in the trained group to an attenuated release of substrates from the 
hypothalamus. They suggested this might be related to a lessened need for vasopressin to 
regulate arterioles and fluid balance during exercise. There has been evidence that 
chronic exercise upregulated OXT gene expression and content in the hypothalamus of 
rats (Gutkowska et al. 2007). 
Oxytocin Gender Differences 
 Females may have higher levels of oxytocin during rest and have twice the 
prevalence of anxiety disorders as their male counterparts (Naja et al. 2017). Males and 
females have complex differences in oxytocin secretion and function. Some observations 
of both humans and animals studies noted different brain regions activated in responses 
to the same stimuli between the sexes. Also, social dynamics with oxytocin exposure 
differed between the sexes in rodents (Naja et al. 2017). These differences are poorly 
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understood, but breakthroughs could change how anxiety disorders are treated for these 
two genders. One interesting difference that may have a large effect is the expression of 
OXT peptide synthase on the OXTR. Females have more OXT peptide synthase and 
more OXTR in the amygdala due to upregulation via estrogen (Naja et al. 2017, 
Neumann et al. 2012).  
Measurement of Oxytocin 
 Recent studies have shown evidence that traditional methods of measurement of 
oxytocin have varied selectivity and may report falsely high and low values (Brandtzaeg 
et al. 2016, Brown et al. 2016). It is hypothesized that this issue arises from oxytocin 
binding strongly to proteins in plasma and serum (Brandtzaeg et al. 2016). To avoid this 
issue, a protein precipitation and an extraction technique were implemented by these 
researchers. This process extracts oxytocin from serum or plasma after removing it from 
the protein and evaporates it to dryness and then reconstitutes the OXT prior to assay. 
HPLC tied to mass spectrometry was reported to have the highest sensitivity with lower 
limits of quantification (LLOQ) as low as 1.0 pg/ml (Brandtzaeg et al. 2016, Zhang et al. 
2011). Unextracted plasma samples were compared to the extracted samples. The 
unextracted samples showed an average of 60 times higher OXT than the extracted 
samples (Brown et al. 2016). Therefore, it is likely that the reason for the modest change 
in the results from other studies was the 60 times higher OXT level in those papers as 
these studies did not extract the OXT from the protein. Extraction of oxytocin may also 
present issues in quantification analysis. There is a possibility with all extraction 
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techniques that there is oxytocin lost during the process. Liquid chromatography has 
excellent selectivity and may be the best method for extraction and quantification.  
 Radioimmunoassay (RIA) and enzyme immunoassay (EIA) techniques have been 
observed to have varied sensitivity and validity when determining oxytocin levels in 
human plasma. These two techniques also require protein extraction for accurate OXT 
analysis. Radioimmunoassay methods may have difficulties detecting OXT 
concentrations below 10 pg/ml (McCullough et al. 2013). This issue persists in most 
enzyme linked immunosorbent assay kits with sensitivities around 17 pg/ml (Arbor 
Assay). The inability to detect plasma levels below 10 pg/ml makes it challenging for 
these techniques to be used in human plasma where basal levels have been reported to be 
as low as 1-10 pg/ml (McCullough et al. 2013). 
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Table 2. Summary of Baseline Oxytocin Measurement 
 
Study Subjects 
Oxytocin 
Concentration (pg/ml) 
Extracted Assay Tissue 
Altemus et al. 2001 Health Women 1.66 (0.10) Yes RIA Plasma 
Chicharro et al. 2001 
Trained vs 
Untrained cyclists 
Trained ~10 
Untrained ~18 
Yes RIA Plasma 
Hew-Butler et al. 2008 
Trained 
Endurance 
Runners 
1.3 (0.2) Yes RIA Plasma 
Jong et al. 2016 Healthy Adults ~2.0 Yes RIA Saliva 
Landgraf et al. 1982 
Healthy Adult 
Men 
~4.1 (2.7) Yes RIA Plasma 
Zhang et al. 2011 Health Adults 2.58 (0.275) Yes LC-MS Plasma 
Bello Et al. 2008 Healthy Men 92.3 No EIA Plasma 
Values shown are mean followed by standard deviation in parentheses. Table 2 presents basal or resting oxytocin concentration 
in various studies in human plasma or saliva. 
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CHAPTER III 
 
METHODS 
 
 
Subjects 
 The study protocol for J.D. Waller’s thesis was reviewed by IRB and approved. 
The plasma samples to be utilized to determine the oxytocin levels were obtained in this 
study and stored in -80°C freezer. Subjects were given ample time to read and ask 
questions prior to signing the informed consent on their first visit. Fifteen individuals 
were approved to be subjects. They completed the screening and were non-tobacco users 
and not taking medications or supplements that would influence metabolism, insulin, and 
hydration status for at least 6 months. Subjects were instructed to maintain their normal 
diet throughout the study. The subjects were normotensive based on their resting blood 
pressure. The participants reported to the laboratory (6-9 a.m.) after an overnight fast and 
had not exercised for at least 24 hrs. They were all given water to drink to prevent 
dehydration when they arrived and during the submaximal exercise.  
 Upon arrival to the laboratory for each visit the subject was seated and rested for a 
minimum of 15 minutes. The first visit was the VO2max treatment as this had to proceed 
the submaximal visit. A heart rate (HR) monitor was placed around their chest (Polar 
monitor) and captured their resting HR. Subjects, then, had a resting blood sample taken 
from an antecubital vein. Subjects rested at least another 5 minutes prior to the graded 
treadmill exercise and were given a water bottle to drink prior to exercise. 
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Maximal Treadmill Graded Exercise 
Subjects had a 5 min warm-up on the treadmill until their HR (Polar monitor) 
reached ~130 bpm. Subjects continuously breathed through a mouthpiece connected to a 
one-way valve which enabled continuous analysis of their expired gases. Subjects wore a 
nose clip which prevented them from breathing through their nose. Thereafter there was 
an increase of 2.5% grade each minute until reaching VO2 max or volitional fatigue. 
Expired gases were collected and analyzed by a ParvoMedics TrueOne 2400 analyzer 
system (ParvoMedics, Sandy, UT, USA) calibrated to known gases. Ratings of perceived 
exertion (RPE) were recorded each minute (Noble et al. 1983). All subjects satisfied at 
least four of the five required criteria for a true VO2max (Midgley et al. 2007; Pescatello 
et al. 2014). Immediately after the test (1-2 minutes) another blood sample was taken 
from an antecubital vein. 
Submaximal Treadmill Exercise 
 Subjects reported back to the laboratory at the same time in a post-absorptive state 
with at least 3 days between visits but no longer than 14 days. As before, they rested for 
at least 15 minutes prior to having a blood sample obtained at rest. They again had a polar 
HR monitor placed around their chest. Subjects were given a 3-5 min warm-up on the 
treadmill. HR was continually monitored during the 70-75% VO2max exercise (Polar 
monitor) and recorded every 5 minutes. VO2 was confirmed in the initial 5 minutes and 1 
minute every 5 minutes during the test to ensure proper intensity. Subject RPE was 
obtained every 5 minutes to further ensure appropriate subjective intensity was 
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maintained. Subjects were given water every 2 minutes. Immediately after the test a post- 
exercise blood sample was obtained within 1-2 minutes of cessation of exercise.  
Study Design 
 A repeated measure, 2 (2 exercise conditions [VO2max and continuous submax]) x 
2 (2 time points [Pre, immediately post]) design was used for this study. After a 
preliminary screening, subjects performed the first exercise session [VO2max] by necessity 
to enable % workload to be determined. The submaximal workload visit occurred within 
seven days and at the same time as the previous visit in a post-absorptive state. 
Blood Collection and Treatment 
 Subject rested at least 15 minutes before blood was obtained from an antecubital 
vein prior to any intervention. Blood was drawn into vacutainer EDTA tubes. Hematocrit 
(Hct) was determined by taking <25l blood drawn into micro-hematocrit capillary tubes, 
sealed and centrifuged (micro centrifuge at 3000 rpm 5 min), and volume ratio 
determined (triplicate). Blood was immediately centrifuged (Beckman Allegra) for 10 
minutes at 3000 rpm (4C). Plasma was aliquoted into microtubes and placed in a -80C 
freezer until analyzed.  
Sampling and Assays 
 Plasma samples were extracted prior to analysis via a Waters Acquity Ultra 
Performance Liquid Chromatography (UPLC) coupled to a Thermo Fisher Q Exactive 
Plus High-Resolution Mass Spectrometer (HRMS) system using techniques described in 
Brandtzaeg, et al. 2016. This process uses a protein precipitation to extract OXT from the 
protein within plasma samples. 5μl of 0.5mM dithiothreitol were added to each sample 
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for reduction of disulfide bonds, and 15μl of 0.5mM iodoacetamide were added to each 
sample for alkylation. The samples were vortexed and then placed in a heat block at 37°C 
for 45 minutes. They were then allowed to cool and then the iodoacetamide was added in 
darkness for 20 min. Then 700μl of 80% LC-MS grade acetonitrile (ACN) was added to 
help with protein precipitation. The samples were vortexed and then placed into a micro-
centrifuge at 12,000 rcf for 20 minutes. Supernatants (900μl) were removed and passed 
through 0.22 µm polypro filters to remove any large particles. These samples were all 
spiked with 10μl of 10ng/ml OXT standard (100 pg) (Sigma-Aldrich). All samples were 
then placed in a speed vacuum system at 45°C and centrifuged until dryness. The dried 
samples then were stored in -80°C until analyzed. They were later reconstituted in 100μl 
of 0.1% formic acid. Most samples required sonication to go into solution. The complete 
process of the extraction can be found in appendix A. All samples were extracted in 
duplicate and were analyzed in triplicate through the UPLC-HRMS system. 
 The UPLC-HRMS -mass spectrometer system used could only detect standards at 
the ~ 0.2 ng/ml consistently so each sample was spiked with internal standard (IS) as 
suggested by Brandtzeg et al (2016). Each sample was spiked with 10 μl of [10 ng/ml] 
standard solution. This was the equivalent to 100 pg added to each sample. The delta 
concentration will be presented as the concentration of OXT in plasma. 
 The UPLC used a binary solvent system consisting of water containing 0.1% 
formic acid and acetonitrile containing 0.1% formic acid. Samples were eluted from a 
Waters Acuity Pentafluorophenyl (PFP) column at a flow rate of 0.3 mL/min. The PFP 
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column contains fluorine groups to provide enhanced retention and selectivity. Elution 
time for OXT was ~2 minutes. 
 The UPLC-HRMS utilized could not consistently detect the low values of 
oxytocin in the plasma. Even with the addition of the 100 pg spike this system was 
unable to assess the peaks for the oxytocin. 
 Values found from liquid chromatography were compared to results from an 
enzyme linked immunosorbent assay kit obtained from Arbor Assays. This kit utilizes a 
similar extraction technique but has the addition of using a C18 Sep-Pak column for 
added sample separation. 800μl of 1% trifluoracetic acid was combined with 800μl 
plasma sample and was vortexed completely before being centrifuged. Supernatant was 
collected and put through the C18 Sep-Pak column after washing the columns with a 
solution of 60% acetonitrile, 1% trifluoracetic acid, and 39% distilled water. Prior to 
extraction through the Sep-Pak column one sample was spiked with 100 pg of oxytocin 
standard. After samples eluted off the column they were transferred to polypropylene 
tubes and brought to dryness in a speed vac. Samples were reconstituted in 350μl of assay 
buffer prior to being plated and analyzed. The complete extraction process can be found 
in Appendix B and protocols for the ELISA can be found in Appendix C. During pilot 
experiments with this ELISA method the first and second wash after loading plasma onto 
the Sep-Pak Column were collected and analyzed along with the eluted sample. This was 
done to measure if any oxytocin was lost during extraction. 
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Preparation of Standard 
 97% HPLC grade Oxytocin acetate salt hydrate was purchased from Sigma-
Aldrich. Standard was constituted in 0.1% formic acid and a serial dilution was utilized to 
create a standard curve. The standard curve consisted of points at 1000 pg/ml, 500 pg/ml, 
250 pg/ml, 50 pg/ml, 25 pg/ml, 5 pg/ml, and 0 pg/ml. These solutions were stored in -
20°C until analyzed by the UPLC-HRMS. 
 Standards for the enzyme linked immunosorbent assay were done in triplicate 
with the OXT standard from the Arbor Assay kit. A serial dilution with the standard was 
performed with assay buffer to make concentrations of 1000 pg/ml, 500 pg/ml, 250 
pg/ml, 100 pg/ml, 50 pg/ml, 25 pg/ml, and 12.5 pg/ml. The sensitivity of measurement 
was noted as 17 pg/ml. Samples were plated in duplicate with 100 μl of reconstituted 
extracted samples resuspended in assay buffer. 
Statistical Analysis 
 A repeated measures, 2 (two exercise conditions [VO2max and 70-75% 
submaximal tests] and 2 times [pre and post] was employed. SPSS v 21 software was 
utilized to process the data with a significance value set at P < 0.05 for significance.  
 
28 
 
CHAPTER IV 
 
RESULTS 
 
 
 Mean age for participants was 22.8 years. The male average age was 22.6 years 
while the female average age was 22.8 years. They had an average body mass index 
(BMI) of 23.4 (SD: 3.5) and a mean resting heart rate of 63.4 (SD: 9.2). The mean 
duration of the max test until exhaustion was 6.9 (SD: 1.1) minutes with an average 
relative VO2 max of 51.1 ml/kg/min (SD: 11.1). Male participants’ mean body fat 
percentage calculated by the Siri equation was 10.2% (SD: 5.8%) while the female mean 
fat percentage was 20.8% (SD: 6.3%). There was no significant change in hematocrit for 
all subjects between beginning and end of each exercise treatment. 
 Both the exercise testing modalities stimulated an increase in heart rate within the 
subjects. During the max test, subjects’ heart rates increased in proportion to the 
workload creating a positive linear relationship to increased workload. All subjects’ heart 
rates increased significantly during the max test with a mean final heart rate of 187.2 ± 
1.77 beats per minute. During the steady state test, subjects’ heart rate increased linearly 
then reached steady state. Mean heart rate during the steady state test was 166.22 ± 3.36 
beats per minute. Subjects took an average of 4-5 minutes to achieve steady state. 
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Table 3. Baseline Descriptive Measures 
 
 
Total Male Female 
n 12 7 5 
Age 22.75 (2.96) 22.43 (2.88) 23.20 (3.35) 
Weight (kg) 68.56 (13.08) 72.14 (15.11) 63.54 (8.59) 
Height (cm) 171.04 (7.53) 174.29 (5.82) 166.5 (7.8) 
BMI 23.37 (3.55) 23.66 (3.96) 22.96 (3.27) 
RHR (bpm) 65.0 (9.17) 63.43 (9.07) 67.2 (9.86) 
Systolic BP (mmHg) 119.67 (9.34) 120.29 (9.83) 118.8 (9.65) 
Diastolic BP (mmHg) 77.83 (7.29) 76.57 (8.04) 79.6 (6.54) 
MAP 91.78 (7.29) 91.14 (8.51) 92.67 (6.02) 
VO2max (L/min) 3.49 (0.95) 4.02 (0.86)* 2.77 (0.47)* 
VO2max (ml/kg/min) 51.14 (11.07) 56.17 (10.32) 44.09 (8.42) 
Max Test Duration (mins) 6.89 (0.3) 7.16 (0.42) 6.52 (0.42) 
Siri BF% 15.32% (8.09%) 11.02% (6.11%)* 21.33% (6.84%)* 
All Values are as “Mean (Standard Deviation)”. * Significantly different between genders (p<0.05). 
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Table 4. Exercise Variables 
 
 
HRmax: 
VO2max 
VO2max 
Duration 
(mins) 
%VO2max: 
Submaximal 
Test 
Mean HR: 
Submaximal 
Test (bpm) 
Total Work 
VO2max 
(Watts) 
Total Work 
Submaximal 
(Watts) 
Overall 187.2 ± 1.77 6.89 ± 0.3 72.71 ± 1.01 166.22 ± 3.36 
876.36 ± 
105.54† 
1345.41 ± 
173.58† 
Male 187.86 ± 2.87 7.16 ± 0.42 73.59 ± 1.43 167.19 ± 4.48 
1064.5 ± 
122.18*† 
1558.32 ± 
164.58† 
Female 186.2 ± 1.77 6.52 ± 0.42 71.48 ± 1.31 164.87 ± 5.63 
612.97 ± 
111.53* 
1047.33 ± 
322.35 
All values are mean ± standard error of the mean. * denotes a p<0.05 significance between the genders. † denotes a p<0.05 
significance between the exercise modalities. 
 
 
Table 5. Hematocrit Changes with Exercise  
 
Time VO2max Test 70-75% VO2max 
Pre- Exercise 46.33 ± 2.19 46.91 ± 2.23 
Immediately Post 
Exercise 
46.37 ± 1.58 46.40 ± 2.10 
Values are presented as percent hematocrit ± standard deviation. 
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 The present study failed to replicate the UPLC-MS results of Brandtzaeg et al. 
2016. Despite multiple attempts at extraction and analysis the values were too low to be 
detected by the mass spectrometer and no data was recorded for these trials. The data 
from the ELISA is the only oxytocin values that will be reported. 
 Resting plasma oxytocin was determined to have a mean concentration of 371.75 
pg/ml ± 215.10. Neither exercise tests had a significant effect on plasma oxytocin levels. 
There was no statistical difference comparing pre- and post- concentration for both 
exercise modalities. Sample duplicates were consistent with no statistical difference 
between them, p>0.5. The standard curve used to compare unknown samples in the 
ELISA had an excellent coefficient of determination, r2=0.996. 
 Sample duplicates had varying degrees of variability. Most duplicates had 
coefficients of variability below 0.1, but there was variability as high as 0.60-0.64 in 
three samples. Coefficients of variability across subjects were high, 57.9%.
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Table 6. ELISA Measured Pre- and Post- Exercise Oxytocin Concentrations 
 
  
Pre- 
Max 1 
Pre- 
Max 2 
Pre- 
Max CV 
Post- 
Max 1 
Post- 
Max 2 
Post- 
Max CV 
Pre- SS 
1 
Pre- SS 
2 
Pre- SS 
CV 
Post- SS 
1 
Post- SS 
2 
Post- 
SS CV 
1 ND ND   ND ND   xxx xxx   xxx xxx   
2 ND ND   808.29 671.51 0.13 ND ND   ND ND   
3 ND ND   ND ND   174.52 136.13 0.17 191.70 133.84 0.25 
4 ND ND   211.98 209.38 0.01 375.78 248.69 0.29 ND ND   
6 ND ND   ND ND   ND ND   xxx xxx   
7 866.84 774.40 0.08 446.58 424.23 0.04 320.25 279.94 0.09 ND ND   
8 ND ND   ND ND   xxx xxx   511.30 623.51 0.14 
11 ND ND   ND ND   344.89 364.31 0.04 244.41 249.40 0.01 
12 323.58 334.90 0.02 ND ND   94.27 250.11 0.64 271.04 198.25 0.22 
13 ND ND   558.84 1390.05 0.6 ND ND   ND ND   
14 ND ND   1275.58 1179.16 0.06 ND ND   ND ND   
15 494.17 565.16 0.09 ND ND   ND ND   ND ND   
All values above are pg/ml. Values represented by “ND” were below the 22.9 pg/ml lower limit of detection and not 
detectable. Values represented by “xxx” signify concentrations higher than the standard curve allowed computation. 
Coefficient of variability (CV) is presented for each quantifiable duplicate. “Max” refers to graded maximal exercise test and 
“SS” refers to the 30 minute steady state exercise test. Coefficient of variability across subjects for all baseline measures was 
57.9%. 
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Figure 1. ELISA Standard Curve 
 
 
Y-axis values represent average optical density read at 450nm with the mean optical 
density of the non-specific binding wells subtracted out. X-axis concentration are pg/ml. 
r2=0.996. 
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Figure 2. ELISA Measured Basal Plasma Oxytocin Concentration Without Values Below 
Detection Limit 
 
Values above are based only on samples analyzed with the ELISA kit that had 
concentrations in the detectable and measurable range. Mean was 371.75 pg/ml, standard 
deviation 215.10 pg/ml. 
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Figure 3. ELISA Measured Basal Plasma Oxytocin Concentration with Values Below 
Detection Limit 
 
Figure 3 includes values below the detection limit of the ELISA kit. Values shown as 
0.00 could not be quantified because they are less than 22.9 pg/ml. Mean concentration 
was 123.92 ± 214.77 pg/ml. 
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CHAPTER V 
 
DISCUSSION 
 
 
 The ELISA methods described above was unable to accurately detect basal 
plasma oxytocin levels. The measured resting level using the extraction and ELISA kit 
was 371.75 ± 215.10 pg/ml. This value falls above the previously believed plasma basal 
levels for males and non-pregnant females of 1-10 pg/ml (McCullough et al. 2013) and 
below the reported levels of Brandtzaeg et al. (2016) of 600-800 pg/ml. ELISA methods 
rely on antibodies to bind specifically to the analyte of interest. The higher concentration 
values could be due to extra binding of the antibodies during the competitive binding 
assay possibly because of excessive proteins present in the samples or other 
contaminants. During the pilot experiments for the ELISA test, the first and second wash 
after plasma loading on the Sep-Pak column was collected. The first wash had too much 
degraded protein material in them to be analyzed. The second wash was analyzed in the 
competitive binding assay and had complete antibody binding (b%/b0 = 102%) thus 
demonstrating that no oxytocin was lost during this wash of the extraction. 
 The results of the ELISA test were puzzling. Roughly half (27 of 46) of the 
samples analyzed had values below the detectable level of the kit. The lower limit of 
detection for this ELISA kit was 22.9 pg/ml with a sensitivity of 17 pg/ml. It is unclear 
whether the inability to detect the oxytocin was related to the values being below the 
detection limit. This would be expected if the previously assumed 1-10 pg/ml basal 
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plasma oxytocin concentration in humans was correct or if the extraction technique 
utilized lost a significant amount of oxytocin. It should be noted that 800 μl of plasma 
was utilized in the purification process to enhance the amount by 8-fold. Thus if the 
plasma samples had 5 pg/ml, it was hoped that the amount would fall above the 22.9 
pg/ml limit of this assay. 
 Based on the increase in subjects’ heart rate during both exercise tests, the 
assumption can be made that the subjects experienced a normal exercise response. 
However, these two exercise stimuli failed to stimulate any detectable changes in plasma 
oxytocin. While it may appear exercise does not stimulate a change, it is possible that 
there is a dose dependent response with exercise. There may be a threshold of exercise 
intensity or duration required to produce a measurable difference in plasma oxytocin. For 
instance, Hew-Butler et al. 2008 observed a significant increase to plasma oxytocin 
following completion of a long duration ultra-marathon. Earlier, it was presented that this 
change was most likely due to changes in subject hydration, but it is possible the 
extended duration of the exercise stimuli also played a role in hormone shift. In contrast, 
the present study controlled for hydration state and this might have influenced the OXT 
response. 
 There were no apparent differences in oxytocin concentrations across genders. 
Both subjects with the highest baseline oxytocin concentrations (subject one and eight) 
were both males. Future research on human oxytocin measurements may benefit from 
assessing subject socio-emotional health prior to assessment. Some of the variation across 
subjects may have been due to differences in mental health. 
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 Despite the accuracy and sensitivity reported by the referenced studies using 
paired high-performance liquid chromatography and the mass spectrometer, the present 
study failed to replicate these results. Based on the mass spectrometer calibration the 
lower limit of quantification was around 200 pg/ml. This is 200 times higher than the 
reported LLOQ of Zhang et al 2011 (1 pg/ml). Brantzaeg et al. 2016 reported linearity 
between 5-2000 pg/ml (r2=0.99). It is possible the present study lost much of the oxytocin 
during the extraction if the bindings were not properly broken. The oxytocin levels in 
plasma, projected to be around 1-10 pg/ml, were extremely low and hard to detect with 
the mass spectrometer. Spiking all samples with 100 pg was required elevate them to the 
sensitive range of the equipment. However, a spike this large does present issues with 
data validity. Specifically, the spike of this size may reduce the ability to determine the 
initial plasma concentration. In addition, this amount of spike may mask small 
fluctuations in OXT that might occur. Even with this large spike, the inability to detect 
the oxytocin was baffling.  
 In future research these samples will hopefully be used and analyzed again via 
UPLC-MS to see if the values are consistant. This will help determine if the values 
obtained during the present study are accurate or are a result of contamination or artifacts 
of the analysis. If the results of this analysis show no oxytocin, the next step would be to 
develop a better extraction process using spiked samples. 
 The only divergence between the methods used for the UPLC in the current study 
and the methods used by Brandtzaeg et al. 2016, was the omittance of a solid phase 
extraction (SPE). Brandtzaeg used a SPE column on line to clean samples as well as 
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enrich and further concentrate them. This additional concentration of the plasma may be 
critical in accurate measurement of oxytocin. As stated earlier, the difficulty in detecting 
plasma oxytocin is in part due to the strong protein binding present in human plasma, as 
well as the staggeringly low concentrations seen in the plasma. A greater amount of 
plasma used in the extraction process might be necessary. While Brandtzaeg et al. (2016) 
used 100 μl of plasma during analysis, Zhang et al. (2011) used 1.4 ml of plasma and 
concentrated each sample prior to analysis. This process would alleviate the difficulties 
the mass spectrometer experiences when trying to detect oxytocin levels in the 1-10 
pg/ml range. In the present study, 800 μl of plasma was utilized in the Eliza purification 
process to try to get samples into the detectable range. In the present study, the equipment 
used did not have the capabilities to add the additional SPE column on the UPLC system. 
Instead, cleaning the samples was accomplished by sample injection through a 0.22-
micron filter after being centrifuged but before being put in the speed vac. Any protein 
that was disturbed during pipetting was removed by using this filter step. Increasing the 
amount of plasma used to increase absolute amount of oxytocin could have been utilized 
as well. Zhang et al. 2011 used 1.4 ml of human plasma combined with SPE before 
analysis via HPLC-MS. In the present study 800μl of plasma was utilized which was 4-
fold higher than the amount suggested by Arbor Assays to further concentrate the 
samples to obtain greater amounts of OXT. 
 When comparing the two methods used to determine plasma oxytocin in this 
experiment, it is clear that the two are measuring different substrates. The assumed issue 
with the MS was the lack of detection below 200 pg/ml. However, those same samples 
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analyzed by the ELISA kit showed values mostly over that 200 pg/ml detection limit. If 
the ELISA measurements were accurate and specific, then the MS should have had no 
problem quantifying oxytocin concentration. The greater selectivity of the UPLC-MS 
combination used lends itself to two theories explaining the data: 1) the mass 
spectrometer is correctly attempting to measure only oxytocin, but the level in human 
plasma is too low for detection in the picogram for the UPLC-MS to detect, and 2) the 
extraction technique used prior to the UPLC-MS was too aggressive, and most if not all 
of the oxytocin was lost during the process. Regardless of which of these scenarios is 
correct, it is abundantly clear that this delicate process needs more research to decipher 
suitable extraction techniques and more in-depth sensitive and selective measures. In 
addition, the extraction used for the ELISA was Arbor Assays generic protein extraction. 
It appears oxytocin is a peptide hormone that might require a specialized protein 
extraction. 
 Based on the data measured from the ELISA, moderate intensity steady state and 
graded maximal exercises both fail to stimulate a sufficient stress response to upregulate 
plasma oxytocin secretion into the sensitivity range for this procedure. Although 
peripheral OXT may not have increased, central OXT may have increased. While social 
and mental stress tests have demonstrated the ability to induce these plasma hormone 
changes, physical stress may not (Jong et al. 2016). The details of the oxytocin response 
to stress is still somewhat a mystery and needs further research to determine what factors 
influence secretion centrally and in the peripheral. 
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 Administration of oxytocin either nasally or intravenous has been proposed as a 
treatment for some anxiety disorders (Naja et al. 2017). Testing of the effectiveness of 
these drugs commonly uses different types of stress tests and measured oxytocin response 
to determine effectiveness of the treatment. While exercise tests are easily controllable 
and can be tailored specifically to each subject, it may be a poor stimulus of the stress 
response associated with plasma oxytocin change. Based on the data presented, 
researchers may want to avoid exercise tests in lieu of social and cognitive tests, such as 
the trier social stress test. 
 Physical activity had been shown to stimulate increased secretion of oxytocin in 
animals. Lang et al. 1983 used forced swimming as a stress stimulus and observed spikes 
in rat plasma oxytocin. While this response was seen in animals, it is less clear in 
humans. This may be due to differences in underlying mechanism, or it could be due to 
the sensitivity of the assays used. According it Brandtzaeg et al. 2016, rat plasma 
oxytocin is in much higher concentration than in humans. With a proper extraction 
technique, the next biggest issue surrounding oxytocin measurement is developing a 
repeatable sensitive measure that can detect the low amounts of OXT seen in human 
plasma.  
 While seemingly good methods exist for detecting plasma oxytocin in humans, 
many are very expensive, not sensitive enough, and are not reproducible. Future research 
should focus on creating reliable methods to measure this stress hormone. A better 
understanding of oxytocin could become key in the detection and treatment of a variety 
of anxiety and mental disorders. Learning oxytocin’s underlying mechanism of actions 
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and further researching its role as a stress hormone may propel future studies on social 
and cognitive development, as well as identify risk factors for development of cognitive 
disorders 
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CHAPTER VI 
 
CONCLUSION 
 
 
 Analysis of plasma oxytocin in humans requires the most precise instrumentation. 
The strong binding with proteins in the plasma must be broken prior to analysis which is 
troublesome for many methods. Resting oxytocin levels in humans is believed to be about 
1-10 pg/ml, but has been recently reported to be closer to 600-800 pg/ml. The supposed 
low concentration previously believed could be due to improper extraction techniques 
being used or errors in the quantification process. However, the low concentration theory 
has more research supporting it. This low level adds further difficulty to the detection 
process. Using a thorough extraction process followed by high performance liquid 
chromatography and mass spectrometry has been reported to have the highest sensitivity 
for oxytocin measurement. Despite the best attempts at replicating the results of previous 
LC-MS studies, the present study failed to detect plasma oxytocin with mass 
spectrometry. While other studies have reported lower limits of detection around 1 pg/ml, 
the present study failed to have any detection below 200 pg/ml. 
 Quantification of plasma oxytocin was compared with that of a commercial 
ELISA kit. This kit had large coefficients of variability across subjects and thus, a normal 
basal level could not be confirmed. Issues surrounding the two methods used to extract 
the proteins seems to be a possible issue. While the UPLC-MS methods utilized a 
complex reduction, alkylation, and protein precipitation process, the ELISA extraction 
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methods relied heavily on separation through C18 Sep-Pak columns. It is suggested that 
these extractions procedures be investigated in the future. 
 Oxytocin changes in response to exercise in humans have been debated. This 
relationship is seen in rats and other animals but has mixed results in humans. The 
present study measured oxytocin before and after two exercise stimuli. A graded maximal 
exercise test and a moderate intensity thirty-minute steady state exercise were utilized for 
comparison. Our methods detected no difference in plasma oxytocin as a result of either 
of the exercise stimuli. It is unclear whether the lack of significant difference between 
exercise stimuli is due to a lack of physiological response, or due to the poor sensitivity 
of the methods used. 
 The data gathered in the present study support the idea that basal oxytocin 
concentrations normally are below 20 pg/ml. Unfortunately, due to the methods used, 
there is no direct data supporting this idea, but the lack of ability for the mass 
spectrometer to detect oxytocin levels suggest that resting levels must be below the 
detection limit of 200 pg/ml. The ELISA also had difficulties detecting oxytocin in many 
of the samples. This is hypothesized as having to do with the higher lower limit of 
detection reported by the kit manufacturer, 22.9 pg/ml. 
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APPENDIX A 
 
STANDARD OPERATION PROCEDURE FOR TOTAL OXT SAMPLE 
PREPARATION PRIOR TO LC-MS ANALYSIS 
 
 
1. Place plasma samples, Tris-HCl, Internal Standard (IS), dithiothreitol (DTT) and 
iodoacetamide (IAM) on the lab bench. Wait until solutions reach 
room temperature so they do not absorb humidity from the air. 
2. Add 100 µL plasma to a 1.5 mL eppendorf vial. 
3. Add 200 µL Tris-HCl buffer (pH 8) to all vials. 
4. Add 10 µL 10 ng/mL IS to all vials. 
5. Vortex all solution at max speed for 10 seconds. 
6. Add 5 µL 0.5 M DTT to all vials. 
7. Place in oven at 37°C for 45 min. 
8. Cool down to room temperature (approx. 10 min). 
9. Add 15 µL 0.5 M IAM to all vials. 
10. Place in darkness at room temperature for 20 min. 
11. Perform protein precipitation (PPT) by adding 700 µL of 80% LC-MS grade 
acetonitrile (ACN) (cold). The water in the 80% ACN PPT solution will be solid ice 
in the freezer (-20°C). Therefore, remove the PPT solution from the freezer approx. 
10 min before PPT is performed so that the ice melts. 
12. Vortex all solution at max speed for 10 seconds. 
13. Place the vials in the centrifuge and spin at approx. 12 000 rcf for 20 min. 
14. Remove 900 µL of the supernatant over to new 1.5 mL Eppendorf vials 
15. Perform speed-vac until dryness. Medium heat is advised (30-40°C).  
16. Resolve the dried sample in 100 µL 0.1% FA. 
17. Vortex approx. 20 seconds per sample to be sure that everything is resolved. 
18. Centrifuge the resolved samples at approx. 12 000 rcf for 5 min. 
19. Transfer supernatant to auto sampler vials. 
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APPENDIX B 
 
PEPTIDE/PROTEIN EXTRACTION PROTOCOL ARBOR ASSAYS 
 
 
1. Mix an equal amount of binding buffer (BB) to the plasma and vortex 
2. Centrifuge at 6,000 x g to 17,000 x g for 20 minutes at 4°C. Collect supernatant 
3. Equilibrate a C18 column by washing with 1 ml elution buffer (EB) followed by 3 x 3 
ml BB. 
4. Load the plasma/BB solution from step 1 onto the washed C18 column 
5. Slowly wash the column with BB (3 ml, twice) and discard the wash. 
6. Elute the peptide slowly with the elution buffer (3 ml, once) and collect eluant in a 
polypropylene tube. 
7. Remove acetonitrile solvent in a centrifugal concentrator. Freeze-dry results solution 
to dryness 
8. Dissolve the residue in a suitable volume of assay buffer provided with the kit. 
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APPENDIX C 
 
ELISA PROTOCOL ARBOR ASSAY CATALOG NUMBER K048-H1 
 
 
1. Pipet 100 µL of samples or standards into wells in the plate.  
2. Pipet 100 µL of Assay Buffer into the maximum binding (B0 or Zero standard) wells. 
3. Pipet 125 µL of Assay Buffer into the non-specific binding (NSB) wells.  
4. Add 25 µL of the DetectX® Oxytocin Conjugate to each well using a repeater pipet. 
5. Add 25 µL of the DetectX® Oxytocin Antibody to each well, except the NSB wells, 
using a repeater pipet. 
6. Shake the plate in a plate shaker at room temperature for 15 minutes to ensure 
adequate mixing of the reagents. Cover the plate with the plate sealer and store at 4°C 
for 16-18 hours.  
7. The following day, remove the TMB Substrate from the refrigerator and allow to 
come to room temperature for at least 30 minutes. Addition of cold Substrate will 
cause depressed signal. 
8. Aspirate the plate and wash each well 4 times with 300 µL wash buffer. Tap the plate 
dry on clean absorbent towels.  
9. Add 100 µL of the TMB Substrate to each well, using a repeater pipet.  
10. Incubate the plate at room temperature for 30 minutes without shaking. 
11. Add 50 µL of the Stop Solution to each well, using a repeater or a multichannel pipet. 
12. Read the optical density generated from each well in a plate reader capable of reading 
at 450 nm. 
 
